292
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

ROBO2 hampers malignant biological behavior and predicts a better prognosis in pancreatic adenocarcinoma

, , , , , , & show all
Pages 955-964 | Received 25 Mar 2021, Accepted 10 May 2021, Published online: 19 Jun 2021

References

  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J. CA Cancer J Clin. 2016;66(2):115–132.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
  • Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet. 2004;363(9414):1049–1057.
  • Gu X, Zhou R, Li C, et al. Preoperative maximum standardized uptake value and carbohydrate antigen 19–9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma. BMC Cancer. 2019;19(1):19.
  • Domyan ET, Branchfield K, Gibson DA, et al. Roundabout receptors are critical for foregut separation from the body wall. Dev Cell. 2013;24(1):52–63.
  • Fish JE, Wythe JD, Xiao T, et al. A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish. Development. 2011;138(7):1409–1419.
  • Hwang DY, Kohl S, Fan X, et al. Mutations of the SLIT2-ROBO2 pathway genes SLIT2 and SRGAP1 confer risk for congenital anomalies of the kidney and urinary tract. Hum Genet. 2015;134(8):905–916.
  • Gonçalves AN, Correia-Pinto J, Nogueira-Silva C. ROBO2 signaling in lung development regulates SOX2/SOX9 balance, branching morphogenesis and is dysregulated in nitrofen-induced congenital diaphragmatic hernia. Respir Res. 2020;21(1):302.
  • Gołos A, Jesionek-Kupnicka D, Gil L, et al. The expression of the SLIT-ROBO family in adult patients with acute myeloid leukemia. Arch Immunol Ther Exp (Warsz). 2019;67(2):109–123.
  • Choi YJ, Yoo NJ, Lee SH. Down-regulation of ROBO2 expression in prostate cancers. Pathol Oncol Res. 2014;20(3):517–519.
  • Je EM, Gwak M, Oh H, et al. Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability. Pathology. 2013;45(7):645.
  • Chang ZW, Dong L, Qin YR, et al. Correlations between gastric cancer family history and ROBO2 and RASSF2A gene methylations. J Can Res Ther. 2016;12(2):597.
  • Dickinson RE, Fegan KS, Ren X, et al. Glucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells. PLoS One. 2011;6(11):e27792.
  • Prasad A, Fernandis AZ, Rao Y, et al. Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. J Biol Chem. 2004;279(10):9115–9124.
  • Nguyen-Ba-Charvet KT, Chédotal A. Role of slit proteins in the vertebrate brain. J Physiol Paris. 2002;96(1–2):91–98.
  • Gröne J, Doebler O, Loddenkemper C, et al. Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. Oncol Rep. 2006;15(6):1437–1443.
  • Schmid BC, Rezniczek GA, Fabjani G, et al. The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells. Breast Cancer Res Treat. 2007;106(3):333–342.
  • Huang Z, Wen P, Kong R, et al. USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration. Int J Cancer. 2015;136(8):1792–1802.
  • Stella MC, Trusolino L, Comoglio PM. The slit/robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis. Mol Biol Cell. 2009;20(2):642–657.
  • Wen P, Kong R, Liu J, et al. USP33, a new player in lung cancer, mediates slit-robo signaling. Protein Cell. 2014;5(9):704–713.
  • Escot S, Willnow D, Naumann H, et al. Robo signalling controls pancreatic progenitor identity by regulating tead transcription factors. Nat Commun. 2018;9(1):5082.
  • Skuja E, Butane D, Nakazawa-Miklasevica M, et al. Deletions in metastatic colorectal cancer with chromothripsis. Exp Oncol. 2019;41(4):323–327.
  • Solyom S, Ewing AD, Rahrmann EP, et al. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 2012;22(12):2328–2338.
  • Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491(7424):399–405.
  • Waddell N, Pajic M, Patch AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518(7540):495–501.
  • Achyut BR, Yang L. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011;141(4):1167–1178.
  • Pinho AV, Van Bulck M, Chantrill L, et al. ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. Nat Commun. 2018;9(1):5083.
  • Han S, Cao C, Tang T, et al. ROBO3 promotes growth and metastasis of pancreatic carcinoma. Cancer Lett. 2015;366(1):61–70.
  • Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol. 2007;39(12):2153–2160.
  • Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196.
  • Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005;65(14):5991–5995.
  • Chen HT, Liu H, Mao MJ, et al. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol Cancer. 2019;18(1):101.
  • Chang CJ, Chao CH, Xia W, et al. p53 Regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol. 2011;13(3):317–323.
  • Gan L, Meng J, Xu M, et al. Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer. Oncogene. 2018;37(6):744–755.
  • Lal G, Hashimi S, Smith BJ, et al. Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a hospital-based cohort Study in Iowa. Ann Surg Oncol. 2009;16(8):2280–2287.
  • Gu M, Guan J, Zhao L, et al. Correlation of ECM1 expression level with the pathogenesis and metastasis of laryngeal carcinoma. Int J Clin Exp Pathol. 2013;6(6):1132–1137.
  • Chen H, Jia WD, Li JS, et al. Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma. Med Oncol. 2011;28(S1):318–325.
  • Lee KM, Nam K, Oh S, et al. ECM1 regulates tumor metastasis and CSC-like property through stabilization of β-catenin. Oncogene. 2015;34(50):6055–6065.
  • Wu Q, Chen D, Luo Q, et al. Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis. Cancer Lett. 2018;437:44–55.
  • Park J, Kim DH, Shah SR, et al. Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases. Nat Commun. 2019;10(1):2797.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.